XML 19 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
$ in Millions
Total
Common stock
Capital in excess of par value
Retained earnings
Accumulated other comprehensive (loss) income
Treasury stock
Non-controlling interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance, treasury stock (in shares)           (21,738,838)  
Beginning balance , common stock (in shares) at Dec. 31, 2019   (128,526,137)          
Beginning balance at Dec. 31, 2019 $ 6,229 $ 16 $ 3,823 $ 4,118 $ (717) $ (1,023) $ 12
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss 364     363     1
Cumulative translation adjustment 88       88    
Gains (losses) on derivatives qualifying as hedges, net of tax (9)       (9)    
Pension liability and postretirement adjustment; net of tax (60)       (60)    
Cash dividends declared (325)     (325)      
Stock options/SSARs (in shares)           57,652  
Stock options/SSARs 3         $ 3  
Vested restricted stock units and awards (5)   (8)     $ 3  
Vested restricted stock units and awards (in shares)           93,039  
Stock-based compensation 36   36        
Redeemable NCI 2   2        
Dividends on non-controlling interest and other (1)           (1)
Ending balance (in shares) at Dec. 31, 2020   (128,526,137)          
Ending balance at Dec. 31, 2020 6,322 $ 16 3,853 4,156 (698) $ (1,017) 12
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance, treasury stock (in shares)           (21,588,147)  
Net loss 273     270     3
Cumulative translation adjustment (848)       (848)    
Gains (losses) on derivatives qualifying as hedges, net of tax 8       8    
Pension liability and postretirement adjustment; net of tax 115       115    
Cash dividends declared (785)     (785)      
Stock options/SSARs (in shares)           159,222  
Stock options/SSARs 11   4     $ 7  
Impact of N&B Merger (in shares)   141,740,461          
Impact of N&B Merger 15,976 $ 18 15,936       22
Conversion of tangible equity units (in shares)   5,460,031          
Conversion of tangible equity units 0 $ 1 (1)        
Vested restricted stock units and awards (5)   (18)     $ 13  
Vested restricted stock units and awards (in shares)           276,280  
Stock-based compensation 54   54        
Redeemable NCI (2)   (2)        
Dividends on non-controlling interest and other (2)           (2)
Ending balance (in shares) at Dec. 31, 2021   (275,726,629)          
Ending balance at Dec. 31, 2021 $ 21,117 $ 35 19,826 3,641 (1,423) $ (997) 35
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance, treasury stock (in shares) (21,152,645)         (21,152,645)  
Net loss $ (1,868)     (1,871)     3
Cumulative translation adjustment (904)       (904)    
Gains (losses) on derivatives qualifying as hedges, net of tax 0            
Pension liability and postretirement adjustment; net of tax 158       158    
Cash dividends declared (815)     (815)      
Stock options/SSARs (in shares)           85,728  
Stock options/SSARs 15   11     $ 4  
Vested restricted stock units and awards (26)   (41)     $ 15  
Vested restricted stock units and awards (in shares)           308,751  
Stock-based compensation 49   49        
Purchase of NCI (5)   1       (6)
Redeemable NCI (5)   (5)        
Dividends on non-controlling interest and other (2)           (2)
Ending balance (in shares) at Dec. 31, 2022   (275,726,629)          
Ending balance at Dec. 31, 2022 $ 17,714 $ 35 $ 19,841 $ 955 $ (2,169) $ (978) $ 30
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beginning balance, treasury stock (in shares) (20,758,166)         (20,758,166)